SG3 Management, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$30,000
-93.0%
2,300
-93.1%
0.00%
-93.8%
Q2 2021$426,000
-77.3%
33,100
-79.9%
0.02%
-55.6%
Q4 2020$1,879,000
+2704.5%
165,000
+2100.0%
0.04%
+1700.0%
Q3 2020$67,0007,5000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders